Iino T, Nagao M, Tanaka H, Yoshikawa S, Asakura J, Nishimori M
Sci Rep. 2024; 14(1):20508.
PMID: 39227655
PMC: 11371834.
DOI: 10.1038/s41598-024-71446-8.
Corino C, Aimo A, Luigetti M, Ciccone L, Ferrari Chen Y, Panichella G
Mol Neurobiol. 2024; 62(3):2945-2954.
PMID: 39192044
PMC: 11790689.
DOI: 10.1007/s12035-024-04442-8.
Gal J, Vary C, Gartner C, Jicha G, Abner E, Ortega Y
J Mol Neurosci. 2024; 74(3):65.
PMID: 38987361
DOI: 10.1007/s12031-024-02239-x.
Steinhoff J, Wagner C, Dahnhardt H, Kosic K, Meng Y, Taschler U
EMBO Rep. 2024; 25(7):2878-2895.
PMID: 38769419
PMC: 11239848.
DOI: 10.1038/s44319-024-00158-x.
He X, Wang M, Sun J, Yu Z, Hu X, Liu Y
Cardiology. 2024; 149(4):383-395.
PMID: 38437799
PMC: 11309070.
DOI: 10.1159/000538081.
Inhibitors of Transthyretin Amyloidosis: How to Rank Drug Candidates Using X-ray Crystallography Data.
Leite J, Costa-Rodrigues D, Gales L
Molecules. 2024; 29(4).
PMID: 38398647
PMC: 10893244.
DOI: 10.3390/molecules29040895.
Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy.
Sha Q, Zhang Y, Wang M, Sun J, Zhang Y, Zhang X
ESC Heart Fail. 2023; 11(1):112-125.
PMID: 37827496
PMC: 10804152.
DOI: 10.1002/ehf2.14543.
Pharmacokinetics and Pharmacodynamics of Patisiran in Patients with hATTR Amyloidosis and with Polyneuropathy After Liver Transplantation.
Badri P, Habtemariam B, Melch M, Clausen V, Arum S, Li X
Clin Pharmacokinet. 2023; 62(10):1509-1522.
PMID: 37639169
DOI: 10.1007/s40262-023-01292-w.
A molecular basis for tetramer destabilization and aggregation of transthyretin Ala97Ser.
Wang Y, Huang C, Liou G, Hsueh H, Liang C, Tseng H
Protein Sci. 2023; 32(4):e4610.
PMID: 36851846
PMC: 10037696.
DOI: 10.1002/pro.4610.
Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid.
Tsai F, Jaeger M, Coelho T, Powers E, Kelly J
Amyloid. 2023; 30(3):279-289.
PMID: 36691999
PMC: 10363573.
DOI: 10.1080/13506129.2023.2167595.
Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy.
Nuvolone M, Girelli M, Merlini G
Int J Mol Sci. 2022; 23(24).
PMID: 36555787
PMC: 9788438.
DOI: 10.3390/ijms232416145.
Clinical and biochemical characterization of hereditary transthyretin amyloidosis caused by E61K mutation.
Chu X, Wang M, Tang R, Huang Y, Yu J, Cao Y
Front Mol Neurosci. 2022; 15:1003303.
PMID: 36311011
PMC: 9596982.
DOI: 10.3389/fnmol.2022.1003303.
Antibody interfaces revealed through structural mining.
Yin Y, Romei M, Sankar K, Pal L, Hoi K, Yang Y
Comput Struct Biotechnol J. 2022; 20:4952-4968.
PMID: 36147680
PMC: 9474289.
DOI: 10.1016/j.csbj.2022.08.048.
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism.
Sanguinetti C, Minniti M, Susini V, Caponi L, Panichella G, Castiglione V
Biomedicines. 2022; 10(8).
PMID: 36009453
PMC: 9405911.
DOI: 10.3390/biomedicines10081906.
Amyloidogenicity assessment of transthyretin gene variants.
Grether N, Napravnik F, Imhof T, Linke R, Brasen J, Schmitz J
Ann Clin Transl Neurol. 2022; 9(8):1252-1263.
PMID: 35903975
PMC: 9380149.
DOI: 10.1002/acn3.51626.
Large Benefit from Simple Things: High-Dose Vitamin A Improves -Related Retinal Dystrophy.
Smirnov V, Wilmet B, Nassisi M, Condroyer C, Antonio A, Andrieu C
Int J Mol Sci. 2022; 23(12).
PMID: 35743034
PMC: 9223508.
DOI: 10.3390/ijms23126590.
Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis.
Ikura H, Endo J, Kitakata H, Moriyama H, Sano M, Fukuda K
Int J Mol Sci. 2022; 23(11).
PMID: 35683015
PMC: 9181426.
DOI: 10.3390/ijms23116336.
Retinoid Homeostasis and Beyond: How Retinol Binding Protein 4 Contributes to Health and Disease.
Steinhoff J, Lass A, Schupp M
Nutrients. 2022; 14(6).
PMID: 35334893
PMC: 8951293.
DOI: 10.3390/nu14061236.
Retinoid Agonists in the Targeting of Heterotopic Ossification.
Pignolo R, Pacifici M
Cells. 2021; 10(11).
PMID: 34831466
PMC: 8617746.
DOI: 10.3390/cells10113245.
Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression.
Adams D, Algalarrondo V, Polydefkis M, Sarswat N, Slama M, Nativi-Nicolau J
Orphanet J Rare Dis. 2021; 16(1):411.
PMID: 34602081
PMC: 8489116.
DOI: 10.1186/s13023-021-01960-9.